SCHEMBL25936274

SCHEMBL25936274

CC[C@@H]1[C@H]2CN(C(=O)OC(C)(C)C)C[C@@H]12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.53
▸ USP2 O75604 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ NAMPT P43490 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ RECQL P46063 1/20 0.39
▸ EPHX1 P07099 1/20 0.39
▸ DDB1 Q16531 1/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ RORC P51449 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25936275 1.00 NR1H2 (0.53) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL24140221 0.89 NR1H2 (0.47) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL29002609 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL6196658 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL5326157 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL24267538 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL5326154 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL24379179 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL713688 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT
SCHEMBL5796688 0.86 NR1H2 (0.61) NR1H2USP2SMN1; SMN2JAK3NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250096-A1 SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250096-A1 SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES MLLT1, BMI1, MEN1 NR1H2 3177/4885USP2 4047/4885SMN1; SMN2 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback